#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16110	16S	1529	1529	99.87	16S.l15.c17.ctg.2	2291	840.6	0	.	n	.	0	A69G	SNP	69	69	A	315	315	G	1008	G,A,T	733,271,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16110	16S	1529	1529	99.87	16S.l15.c17.ctg.2	2291	840.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1696	1696	T	1028	T	1028	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16110	16S	1529	1529	99.87	16S.l15.c17.ctg.2	2291	840.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1430	1430	C	1021	C,A	1020,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27942	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4173	836.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	2011	2011	A	1250	A,G,C	1248,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27942	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4173	836.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2645	2645	C	980	C,T	978,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27942	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4173	836.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2719	2719	A	908	A,C,G	906,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27942	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4173	836.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3271	3271	C	908	C,A,T,G	904,2,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	2444	folP	852	852	99.88	folP.l15.c4.ctg.1	2058	148.1	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1068	1070	AAA	248;248;248	A;A;A	247;247;247	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	2444	folP	852	852	99.88	folP.l15.c4.ctg.1	2058	148.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1299	1301	AGC	240;239;240	A,T,G;G;C	238,1,1;239;240	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5706	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3971	179.4	1	SNP	p	S91F	0	.	.	271	273	TCC	838	840	TCC	192;194;195	T,G,C;C;C,A	190,1,1;194;194,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5706	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3971	179.4	1	SNP	p	D95N	0	.	.	283	285	GAC	850	852	GAC	209;208;209	G;A,C;C	209;207,1;209	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5706	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3971	179.4	1	SNP	p	D95G	0	.	.	283	285	GAC	850	852	GAC	209;208;209	G;A,C;C	209;207,1;209	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2256	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1924	146.2	1	SNP	p	G45D	0	.	.	133	135	GGC	804	806	GGC	262;261;261	G;G;C	262;261;261	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1216	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1500	101.2	0	.	n	.	0	A197.	DEL	197	197	A	828	828	A	247	A	247	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5242	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3429	190.8	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1854	1856	GCA	245;246;247	G;C,T;A	245;245,1;247	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5242	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3429	190.8	1	SNP	p	D86N	0	.	.	256	258	GAC	807	809	GAC	236;236;238	G;A;C,A	236;236;237,1	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5242	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3429	190.8	1	SNP	p	S87W	0	.	.	259	261	AGT	810	812	AGT	236;237;235	A,T;G,A;T	235,1;236,1;235	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5242	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3429	190.8	1	SNP	p	S87I	0	.	.	259	261	AGT	810	812	AGT	236;237;235	A,T;G,A;T	235,1;236,1;235	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5242	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3429	190.8	1	SNP	p	S87R	0	.	.	259	261	AGT	810	812	AGT	236;237;235	A,T;G,A;T	235,1;236,1;235	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5242	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3429	190.8	1	SNP	p	S88P	0	.	.	262	264	TCC	813	815	TCC	239;237;238	T;C;C,T	239;237;236,2	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4710	parE	1986	1986	100.0	parE.l15.c30.ctg.1	3271	179.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1978	1980	GGC	281;275;274	G,C;G;C,T	280,1;275;273,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4488	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	184.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1596	1598	GCA	260;263;260	G;C,G,A;A	260;261,1,1;260	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4488	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	184.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1599	1601	ATC	261;260;263	A;T,C;C,G	261;259,1;262,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4488	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	184.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1611	1613	GTG	264;263;261	G;T,G;G,A	264;262,1;260,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4488	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	184.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1611	1613	GTG	264;263;261	G;T,G;G,A	264;262,1;260,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4488	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	184.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2115	2117	ACC	263;263;263	A;C;C	263;263;263	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4488	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	184.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2169	2171	GCG	238;239;239	G;C;G,T	238;239;238,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4488	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	184.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2169	2171	GCG	238;239;239	G;C;G,T	238;239;238,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4488	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	184.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2292	2294	GGC	265;267;268	G;G;C	265;267;268	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4488	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	184.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2301	2303	GGC	266;267;267	G;G;C	266;267;267	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4488	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	184.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2319	2321	CTG	260;260;260	C,T;T,G;G	259,1;259,1;260	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6226	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3637	213.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1871	1873	CCG	274;276;278	C,T;C;G	273,1;276;278	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2952	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2499	147.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	876	876	C	204	C	204	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	312	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1158	23.7	0	.	p	.	0	H217N	NONSYN	649	651	CAT	774	776	AAT	6;6;6	A;A;T	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	312	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1158	23.7	0	.	p	.	0	D218N	NONSYN	652	654	GAT	777	779	AAT	6;6;6	A;A;T	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	312	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1158	23.7	0	.	p	.	0	A222V	NONSYN	664	666	GCT	789	791	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	312	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1158	23.7	0	.	p	.	0	V226A	NONSYN	676	678	GTA	801	803	GCG	3;4;4	G;C;G	3;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	312	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1158	23.7	0	.	p	.	0	.	MULTIPLE	700	702	ACT	824	826	GTA	5;5;5	G;T;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	312	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1158	23.7	0	.	p	.	0	N237K	NONSYN	709	711	AAC	833	835	AAG	5;5;5	A;A;G	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	312	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1158	23.7	0	.	p	.	0	D238fs	FSHIFT	712	712	G	836	836	G	5	G	5	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3200	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1672	234.6	0	.	p	.	0	G120N	NONSYN	358	360	GGC	823	825	AAC	266;267;267	A;A;C	266;267;267	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3200	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1672	234.6	0	.	p	.	0	Y216_S217del	DEL	646	646	T	1111	1111	T	285	T,G	284,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3200	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1672	234.6	1	SNP	p	D121N	0	.	.	361	363	GAC	826	828	GAC	270;270;274	G;A;C,T	270;269;272,1	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3200	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1672	234.6	1	SNP	p	A121D	1	.	.	361	363	GAC	826	828	GAC	270;270;274	G;A;C,T	270;269;272,1	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10960	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5427	252.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2225	2227	CAT	268;265;267	C;A;T	268;265;267	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1570	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1535	127.4	1	SNP	p	V57M	1	.	.	169	171	ATG	731	733	ATG	281;282;278	A;T,C;G	281;280,2;278	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
